In recent years, the excellent biocompatibility, modifiability, and low immunogenicity of biomembrane nanosystems have significantly advanced the development of tumor immunotherapy.
In recent years, with the development of biomedicine, the cell membrane-mediated nano-drug delivery system based on biomimetic technology has become a promising delivery strategy for targeted tumor therapy using nanotechnology.